Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

BioLine RX Ltd ADR buy Quitte

Start price
€182.03
17.05.18 / 50%
Target price
€270.00
05.06.18
Performance (%)
-3.21%
End price
€176.18
05.06.18
Summary
This prediction ended on 05.06.18 with a price of €176.18. With a performance of -3.21%, the BUY prediction for BioLine RX Ltd ADR by Quitte closed slightly in the red. Quitte has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
BioLine RX Ltd ADR 6.250% 6.250% -54.667% -70.940%
iShares Core DAX® 0.597% 3.083% 16.090% 16.439%
iShares Nasdaq 100 0.899% 5.338% 29.239% 56.431%
iShares Nikkei 225® 1.775% -1.206% 6.823% 4.774%
iShares S&P 500 0.990% 3.500% 24.956% 47.182%

Comments by Quitte for this prediction

In the thread BioLine RX Ltd ADR diskutieren
Prediction Buy
Perf. (%) -3.21%
Target price 18.000
Change
Ends at 05.06.18

könnte langsam was werden

Prediction Buy
Perf. (%) -3.21%
Target price 18.000
Change
Ends at 05.06.18

(Vom Mitglied beendet)